ImmunityBio (IBRX) Share-based Compensation Growth (1y) (2015 - 2025)
ImmunityBio (IBRX) Share-based Compensation Growth (1y) (2015 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 118.32% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -40.86% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 0.18% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 5,886.05% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | ImmunityBio | 7.60 Bn | 7.22 Bn | 43.97 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -322.47% |
| Sep 30, 2025 | 469.26% |
| Jun 30, 2025 | 139.41% |
| Dec 31, 2024 | 16.16% |
| Sep 30, 2024 | 218.44% |
| Jun 30, 2024 | 63.03% |
| Mar 31, 2024 | -64.45% |
| Dec 31, 2023 | 185.41% |
| Sep 30, 2023 | -85.74% |
| Jun 30, 2023 | -69,840.00% |
| Mar 31, 2023 | 2,824.19% |
| Dec 31, 2022 | -378.27% |
| Sep 30, 2022 | 174.96% |
| Jun 30, 2022 | -99.92% |
| Mar 31, 2022 | -97.57% |
| Dec 31, 2021 | 456.17% |
| Sep 30, 2021 | -1,241.67% |
| Jun 30, 2021 | 5,447.52% |
| Mar 31, 2021 | 3,087.08% |
| Dec 31, 2020 | -152.24% |